- De Zorzi out for 177 as S.Africa power to 413-5 against Bangladesh
- 'CEO of supercute': Hello Kitty turns 50
- Australia head coach McDonald handed new deal until 2027
- Visual artist grabs 'decisive moment' to nurture Chad art scene
- Industrial slump leaves Germany on brink of recession
- 'I'm terrified': French auteur Audiard hits Oscars trail for 'Emilia Perez'
- New Indonesia defence chief harks back to dictator's rule
- In Tennessee, the despair of gun control advocates
- US economy's solid growth unlikely to register at ballot box
- 'A treasure': Japan's Ohtani a hometown hero win or lose in World Series
- Botswana votes with ruling party seeking to extend six decades of power
- Bitcoin close to record as cautious markets eye US election
- Hometown hero Volpe lives dream with grand slam for Yankees
- Rested relief pitchers please Roberts even after Dodgers defeat
- UK's Labour govt prepares to deliver decisive first budget
- Beijing files WTO complaint over EU's new taxes on Chinese EVs
- Volpe's grand slam helps Yankees avoid World Series sweep
- Taiwan battens down for Super Typhoon Kong-rey
- MotoGP world title in sight as Martin, Bagnaia set for Sepang duel
- 'New wave' as start-up sweeps up Thai ocean plastic
- Botswana votes with ruling party aiming to extend six decades of power
- How harmful are microplastics to human health?
- Are bioplastics really the wonder alternative to petro plastics?
- EU's extra tariffs of up to 35.3% on Chinese EVs angers Beijing
- Rumble in the Jungle remembered after 50 years
- Trump risks backlash with anti-trans ads targeting Harris
- Alzheimer's patient 'relieved' at Quebec's assisted suicide policy shift
- Who should get paid for nature's sequenced genes?
- Bodies found as torrential rains slam Spain
- Harris urges US to turn page on Trump 'chaos' in mass White House rally
- Climate change driving 'record threats to health': report
- Harris warns of 'obsessed' Trump power grab at mass Washington rally
- Harris warns against Trump's power grab bid in final election warning
- Southampton, Brentford scrape into League Cup quarter-finals
- PGA players council seeks smaller fields, fewer full tour spots
- Napoli extend lead at top of Serie A with win at AC Milan
- Harris to slam 'unstable' Trump at Washington rally
- Jennifer Lopez to boost Harris at glitzy Las Vegas event
- Global stocks mixed as markets await Big Tech results
- Seven missing as torrential rains slam Spain
- Three-person crew blasts off for China's Tiangong space station
- Google reports strong growth driven by AI, Cloud
- Kyiv announces new mobilisation drive as Russia advances
- Release of new single featuring late One Direction star postponed
- Alcaraz breezes through opener at Paris Masters
- Bolivia 'going from bad to worse': At the barricades with Morales supporters
- Biden unveils $3 bn US ports boost, takes aim at Trump
- EU slaps extra tariffs of up to 35.3% on Chinese EVs
- England boss Borthwick has no qualms over starting Slade against All Blacks
- 'Tootsie' star Teri Garr dies aged 79
NGG | -1.35% | 65.12 | $ | |
RELX | -0.52% | 47.91 | $ | |
RBGPF | 100% | 62.35 | $ | |
SCS | -3.11% | 12.21 | $ | |
RYCEF | 0.55% | 7.25 | $ | |
BCC | -5.3% | 131.64 | $ | |
CMSC | -0.65% | 24.57 | $ | |
CMSD | -0.16% | 24.84 | $ | |
RIO | 0.6% | 66.58 | $ | |
VOD | -2.8% | 9.28 | $ | |
BCE | -0.71% | 32.46 | $ | |
BTI | -1.31% | 34.46 | $ | |
JRI | -0.69% | 12.98 | $ | |
GSK | 0.76% | 38.17 | $ | |
AZN | -1.05% | 75.22 | $ | |
BP | -5.76% | 29.36 | $ |
Bosses resign at Japan health supplement firm probing deaths
The chairman and president of a major Japanese dietary supplement maker announced their resignation on Tuesday, as the company probes dozens of deaths potentially linked to products meant to lower cholesterol.
Kobayashi Pharmaceutical is at the centre of a health scare linked to its over-the-counter tablets containing red yeast rice, which is fermented with a mould culture.
The company's board released a damning external report on Tuesday that said the firm had failed to prioritise consumer safety and acted with an "insufficient sense of urgency".
Red yeast rice or "beni koji" has been used in food, alcoholic drinks and folk medicine for centuries around East Asia.
Medical studies say it can improve cholesterol levels but also warn of a risk of organ damage depending on the ingredient's chemical make-up.
Kobayashi Pharmaceutical said president Akihiro Kobayashi and chairman Kazumasa Kobayashi were leaving their posts. Both men belong to the firm's founding family.
The decision was made "to clarify executive responsibility over a series of actions by our company related to the 'beni koji' issue", it said in a statement.
The scandal erupted in March when the company, a household name in Japan, recalled three brands of dietary supplements after customers complained of kidney problems.
It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and the government inspected the firm's facilities.
- Damning report -
Then last month, the company said it was probing a total of 80 deaths possibly connected to its pills, and investigating whether organs other than kidneys were harmed.
At the time the government called Kobayashi Pharmaceutical's delay in reporting the number of cases under investigation "extremely regrettable".
The report by a team of external lawyers released on Tuesday also criticised the firm's handling of the matter.
It said that in mid-January and early February, the company began to receive reports of kidney problems from doctors.
"Kobayashi Pharmaceutical had never before received multiple reports of serious cases from doctors in such a short period of time," the report said.
"Despite this, the company did not immediately consider disclosure to consumers, acting with an insufficient sense of urgency."
The company should have recalled the products right away and reported the incident, but it only decided to do so after conducting internal probes, the lawyers alleged.
Kobayashi Pharmaceutical's new president is Satoshi Yamane, previously head of sustainability policy, the company said.
Outgoing president Akihiro Kobayashi, who has expressed his intention to take responsibility for any harm caused, will remain in an executive role to manage compensation-related matters, it added.
I.Meyer--BTB